Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001378417 | SCV001575980 | pathogenic | Sandhoff disease | 2023-04-16 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with Sandhoff disease (PMID: 26582265). ClinVar contains an entry for this variant (Variation ID: 1067213). This variant disrupts a region of the HEXB protein in which other variant(s) (p.Cys534) have been determined to be pathogenic (PMID: 29448188, 30075786). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Met522Leufs*2) in the HEXB gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 35 amino acid(s) of the HEXB protein. |
Fulgent Genetics, |
RCV001378417 | SCV005666654 | likely pathogenic | Sandhoff disease | 2024-04-23 | criteria provided, single submitter | clinical testing |